MedTrace Logo

Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer

NCT01799395 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2017-09-12

No results posted yet for this study

Summary

Lung cancer may cause central airway obstruction through several different mechanisms (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis).

The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.

Conditions

Sponsors & Collaborators

  • Maggiore Bellaria Hospital, Bologna

    lead OTHER

Principal Investigators

  • Rocco Trisolini, M.D. · Maggiore Bellaria Hospital, Bologna, Italy

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799395 on ClinicalTrials.gov